Literature DB >> 23907768

Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese.

Guo-zhong Chen1, Xiao-yun Shan, Gan-ping Cheng, Hong-miao Tao.   

Abstract

BACKGROUND: Cyclooxygenase-2 (COX-2) catalyzes the formation of prostaglandins that contribute to the inflammation in atherosclerosis. The aim of the present study was to investigate the relationship between two polymorphisms (-1195G>A and -765G>C) in the COX-2 gene and subtypes of ischemic stroke in a Chinese population.
METHODS: Genomic DNA of 224 patients with large artery atherosclerosis (LAA), 329 patients with small vessel occlusion (SVO), and 450 controls were genotyped for the COX-2 1195G>A (rs689466) and -765G>C (rs20417) polymorphisms using polymerase chain reaction-restriction fragment length polymorphism. Chi-square test and logistic regression analysis were performed for association analysis.
RESULTS: The frequencies of variant allele with -1195G>A and -765G>C polymorphisms were 0.46 and 0.22, respectively. The -1195GA genotype and 1195A allele carriers were identified independently to be related with ischemic stroke (adjusted OR = 1.51, 95 % CI: 1.09-2.10, P = 0.02; OR = 1.45, 95 % CI: 1.06-1.97, P = 0.02) and SVO (adjusted OR = 1.57, 95 % CI: 1.07-2.30, P = 0.02; OR = 1.50, 95 % CI: 1.05-2.16, P = 0.03). In contrast, the 1195G>A polymorphism was not associated with LAA. No relationship between the -765G>C polymorphism and risk of either ischemic stroke was observed. The linkage disequilibrium analysis showed that -1195G>A and -765G>C SNPs are moderate linkage disequilibrium in this study population (D' = 0.72, r (2) = 0.16). Compared with G-1195-G-765 haplotype, the haplotype of A-1195-G-765 showed significant increased risk of ischemic stroke (OR = 1.27, 95 % CI: 1.05-1.54, P = 0.02) and SVO (OR = 1.27, 95 % CI: 1.02-1.58, P = 0.03) but not LAA.
CONCLUSIONS: In conclusion, we found that -1195G>A polymorphism and A-1195-G-765 haplotype of COX-2 were associated with susceptibility to ischemic stroke in a Chinese population. The effects were confined to SVO among the stroke subtypes rather than to LAA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907768     DOI: 10.1007/s12031-013-0078-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

Review 1.  The global stroke initiative.

Authors:  Ruth Bonita; Shanthi Mendis; Thomas Truelsen; Julien Bogousslavsky; James Toole; Frank Yatsu
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

2.  A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia.

Authors:  Cui Xie; Mian Zhi Yao; Jiang Bo Liu; Li Kuan Xiong
Journal:  Cytokine       Date:  2011-10-21       Impact factor: 3.861

3.  Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.

Authors:  J Orbe; O Beloqui; J A Rodriguez; M S Belzunce; C Roncal; J A Páramo
Journal:  Clin Chim Acta       Date:  2006-02-03       Impact factor: 3.786

Review 4.  Genetics and ischaemic stroke.

Authors:  A Hassan; H S Markus
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

5.  Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults.

Authors:  Alessandro Pezzini; Mario Grassi; Elisabetta Del Zotto; Silvana Archetti; Raffaella Spezi; Veronica Vergani; Deodato Assanelli; Luigi Caimi; Alessandro Padovani
Journal:  Stroke       Date:  2005-02-03       Impact factor: 7.914

6.  Endothelial NO synthase gene polymorphisms and risk of ischemic stroke: a meta-analysis.

Authors:  Hong-miao Tao; Guo-zhong Chen
Journal:  Neurosci Res       Date:  2009-04-10       Impact factor: 3.304

7.  Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

Authors:  Rozenn N Lemaitre; Kenneth Rice; Kristin Marciante; Joshua C Bis; Thomas S Lumley; Kerri L Wiggins; Nicholas L Smith; Susan R Heckbert; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-11-01       Impact factor: 5.162

8.  A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.

Authors:  Francesco Cipollone; Elena Toniato; Stefano Martinotti; Maria Fazia; Annalisa Iezzi; Chiara Cuccurullo; Barbara Pini; Sebastiano Ursi; Gianfranco Vitullo; Maurizio Averna; Marcello Arca; Anna Montali; Filomena Campagna; Sante Ucchino; Francesco Spigonardo; Stefano Taddei; Agostino Virdis; Giovanni Ciabattoni; Alberto Notarbartolo; Franco Cuccurullo; Andrea Mezzetti
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

9.  An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke.

Authors:  Chaeyoung Lee; Minyoung Kong
Journal:  Stroke       Date:  2007-08-16       Impact factor: 7.914

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  5 in total

1.  COX-2 rs20417 Polymorphism Is Associated with Stroke and White Matter Disease.

Authors:  Jamary Oliveira-Filho; Ana C P Ornellas; Cathy R Zhang; Luciana M B Oliveira; Théo Araújo-Santos; Valeria M Borges; Laís M G B Ventura; Francisco J F B Reis; Roque Aras; André M Fernandes; Jonathan Rosand; Steven M Greenberg; Karen L Furie; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-05-06       Impact factor: 2.136

2.  Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population.

Authors:  Zhongqiu Zhang; Yanping Mei; Mengqiu Xiong; Fang Lu; Xianghong Zhao; Junrong Zhu; Bangshun He
Journal:  Pharmgenomics Pers Med       Date:  2021-08-13

3.  Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population.

Authors:  Lei Zhao; Jinghuan Fang; Muke Zhou; Jie Zhou; Lihua Yu; Ning Chen; Li He
Journal:  BMC Neurol       Date:  2019-11-17       Impact factor: 2.474

4.  Association of the cyclooxygenase-2 1759A allele with migraine in Chinese Han individuals.

Authors:  Xinying Guan; Changhong Dong; Pinhuan Zhu; Cheng Chen; Teng Wang; Mengping Wu; Xin Dong
Journal:  PLoS One       Date:  2020-09-30       Impact factor: 3.240

5.  EP3 Receptor Deficiency Improves Vascular Remodeling and Cognitive Impairment in Cerebral Small Vessel Disease.

Authors:  Na Liu; Jie Tang; Yang Xue; Vincent Mok; Miaoyi Zhang; Xue Ren; Yilong Wang; Jianhui Fu
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.